The Role of Pre-emptive Analgesia With Qutenza (Topical Capsaicin 8%) in Preventing Neuropathic Pain Following Lower Limb Amputation: a Pilot Randomised Controlled Study
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Astellas Pharma Europe Ltd
- 21 Dec 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2012-001587-30).
- 26 Sep 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
- 14 Jan 2013 New trial record